Literature DB >> 34200018

CT-Detected Subsolid Nodules: A Predictor of Lung Cancer Development at Another Location?

Anton Schreuder1, Mathias Prokop1, Ernst T Scholten1, Onno M Mets2, Kaman Chung1,3, Firdaus A A Mohamed Hoesein4, Colin Jacobs1, Cornelia M Schaefer-Prokop1,3.   

Abstract

The purpose of this case-cohort study was to investigate whether the frequency and computed tomography (CT) features of pulmonary nodules posed a risk for the future development of lung cancer (LC) at a different location. Patients scanned between 2004 and 2012 at two Dutch academic hospitals were cross-linked with the Dutch Cancer Registry. All patients who were diagnosed with LC by 2014 and a random selection of LC-free patients were considered. LC patients who were determined to be LC-free at the time of the scan and all LC-free patients with an adequate scan were included. The nodule count and types (solid, part-solid, ground-glass, and perifissural) were recorded per scan. Age, sex, and other CT measures were included to control for confounding factors. The cohort included 163 LC patients and 1178 LC-free patients. Cox regression revealed that the number of ground-glass nodules and part-solid nodules present were positively correlated to future LC risk. The area under the receiver operating curve of parsimonious models with and without nodule type information were 0.827 and 0.802, respectively. The presence of subsolid nodules in a clinical setting may be a risk factor for future LC development in another pulmonary location in a dose-dependent manner. Replication of the results in screening cohorts is required for maximum utility of these findings.

Entities:  

Keywords:  biomarkers; computed tomography; epidemiology; lung neoplasm; risk

Year:  2021        PMID: 34200018     DOI: 10.3390/cancers13112812

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  1 in total

1.  Sequential pulmonary resections by uniportal video-assisted thoracic surgery for bilateral multiple pulmonary nodules.

Authors:  Guangwen Xu; Gaoxiang Wang; Xinyu Mei; Mingsheng Wu; Tian Li; Mingran Xie
Journal:  Front Oncol       Date:  2022-10-03       Impact factor: 5.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.